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Functional Chimeras of the Human a7 Acetylcholine Receptor Provide In-
sights into Allosteric Modulation
Edom Seyoum, Tommy S. Tillman, Yan Xu, Pei Tang.
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
The human a7 neuronal acetylcholine receptor (a7nAChR) is a promising
drug target for treatment of psychiatric and neurological disorders. A group
of positive allosteric modulators (PAMs) specific to a7nAChR are thought
to act through the transmembrane domain (TMD), but the structural basis
of functional modulation remains unclear. In this study, we constructed mul-
tiple chimeras between the TMD of human a7nAChR and the extracellular
domain (ECD) of a bacterial homolog, ELIC, for which a high-resolution
structure has been determined. Functions of the chimeras were evaluated in
Xenopus oocytes by two-electrode voltage clamp electrophysiology. Func-
tional ELIC-a7nAChR chimeras were obtained when their ECD-TMD inter-
faces were modified to resemble either the ELIC or a7nAChR interface,
but only the latter chimera with the entirely native a7nAChR TMD retained
the unique pharmacology of a7nAChR evoked by the modulators, including
insensitivity to the anesthetic propofol, potentiation by the PAMs ivermectin,
PNU-120596, and TQS, as well as activation by 4BP-TQS. None of the ELIC-
a7nAChR chimeras exhibited the fast desensitization characteristic of
a7nAChR. Functional analysis of a series of chimeras indicated that efficient
coupling at loop 7, in addition to efficient coupling at loop 2 or loop 9, was
essential for a channel to be functional. The most efficient coupling at the
ECD-TMD interface required optimization of all three loops. Altogether,
the study suggests the interdependent of the TMD on the ECD-TMD interface
for channel gating, desensitization, and allosteric modulation. (Funded in
part by grants from the NIH: R01GM069766, R01GM057257, and
R37GM049202)
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Direct Interaction of RIC-3 with the Intracellular Domain of Eukaryotic
Cationic Pentameric Ligand-Gated Ion Channels
Sita Nirupama Nishtala, Nelli Mnatsakanyan, Michaela Jansen.
TTUHSC, Lubbock, TX, USA.
Eukaryotic pentameric ligand-gated ion channels (pLGIC) represent targets for
a wide variety of drugs such as skeletal muscle relaxants, anti-psychotics, anti-
epileptics and drugs against Parkinson’s and Alzheimer’s diseases. Each sub-
unit consists of an extracellular domain (ECD), a transmembrane domain
(TMD) with 4 a-helical segments, and an intracellular domain (ICD) that is
4-14 amino acids long in prokaryotes and ~50-270 amino acids in eukaryotes.
The ICD of eukaryotes has been implicated in modulating single channel
conductance and kinetic properties of the channel. Additionally, it interacts
with cytosolic proteins such as the resistance to inhibitors of cholinesterase pro-
tein, RIC-3, that affects plasma membrane-expression of some pLGIC. We
created chimeras by introducing the ICD of cationic (5-HT3A , nACh a7) as
well as anionic (Glycine a1, GABAA r1) eukaryotic pLGICs into the Gloeo-
bacter violaceus pLGIC, GLIC, a well-studied prokaryotic homologue, that
only contains ECD and TMD. Electrophysiological experiments after X. laevis
oocyte expression (EC50 and IC50) demonstrate that for each of the four
chimera sets, we have constructs that act as functional proton-gated ion chan-
nels, similar to the parent GLIC. Co-expression of cationic chimeras as well as
wild-type pLGIC together with RIC-3 showed significant changes in current
amplitudes, whereas RIC-3 did not affect anionic receptor chimeras or wild-
type channels. We established that cationic chimeras and RIC-3, both overex-
pressed and purified to homogeneity from E. coli, bind to each other. Currently,
we are using the chimeras to identify interacting proteins in native brain lysates.
Our results clearly demonstrate a direct interaction between the ICD of cationic
pLGIC and RIC-3. Specific interaction points will be identified in further
studies.
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The Prokaryote Ligand-Gated Ion Channel Elic Captured in a Pore
Blocker-Bound Conformation by the Alzheimer’s Disease Drug Meman-
tine
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1KU Leuven, Lab of Structural Neurobiology, Leuven, Belgium, 2University
of Cambridge, Department of Biochemistry, Cambridge, United Kingdom,
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Australia, 4VillaPharma Research, Murcia, Spain, 5Janssen R&D, Molecular
Sciences, Beerse, Belgium.Pentameric ligand-gated ion channels (pLGICs) catalyze the selective transfer
of ions across the cell membrane in response to a specific neurotransmitter. A
variety of chemically diverse molecules block ion conduction by plugging the
channel pore. Understanding the structural basis of pore block is important, as
some of these molecules, including the antipsychotic chlorpromazine, the local
anaesthetic lidocaine and the Alzheimer’s disease drug memantine exert their
therapeutic effects by specifically blocking these and other receptors. In this
study, we report X-ray crystal structures of a prokaryote model ion channel
ELIC containing a pore mutation F16’S, which is inhibited by pore blockers
with affinities similar to human pLGICs. Structures in complex with meman-
tine and its brominated derivative, Br-memantine, reveal that these pore
blockers bind at the extracellular entryway of the channel pore, and cause a
structural change, stabilizing the pore-lining helices in a conformation that is
more closed than in the unbound structure. In addition, we observe that mem-
antine binds at the agonist binding site, where it can act as a competitive antag-
onist. We further investigated the conformational dynamics of the pore domain
by using voltage clamp fluorometry, which demonstrated that the pore helix
orientation changes in opposite directions during pore block and channel acti-
vation, consistent with the crystal structures. These data are the first to reveal a
conformational change in the pore initiated by a channel blocker, and have
important implications for the action of drugs such as memantine which bind
to channel pores.
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Probing Pentameric Ligand-Gated Ion Channels with Bromoform Reveals
Many Interconnected Anesthetic Binding Sites
Benoist Laurent1, Samuel Murail1, Ludovic Sauguet2,3, Marc Delarue2,
Marc Baaden1.
1Laboratoire de Biochimie The´orique, CNRS, UPR9080, Univ. Paris Diderot,
Sorbonne Paris Cite´, Paris, France, 2Unite´ de Dynamique Structurale des
Macromole´cules, Institut Pasteur, UMR 3258, CNRS, Paris, France, 3Groupe
Re´cepteurs-Canaux, Institut Pasteur, URA 2182, CNRS, Paris, France.
Sauguet et al. recently solved the structure of the pentameric ligand-gated ion
channel GLIC in complex with the general anesthetic bromoform [1]. This
structure highlights three binding sites in an intra-subunit cavity close to the
propofol and desflurane binding sites previously described by Nury et al. [2].
Additionally, a F238A (F14’A) mutant reveals a supplementary inter-subunit
binding site.
In this work we characterize these and additional sites by computational
methods. We combine several approaches to address three key questions: (i)
are the crystal binding sites spontaneously accessible? (ii) can bromoform
travel from one site to another? (iii) what is the bromoform affinity for each
binding site? Molecular dynamics (MD) simulations of flooding the receptor
with bromoform recover most of the experimentally observed sites, with a
modulated occupancy between the open and the locally closed conformations.
Hundreds of short MD simulations were carried out to extensively explore the
binding pockets, providing data on possible routes connecting them. These sim-
ulations furthermore highlight residues that may play key roles in controlling
the interaction between anesthetic and receptor molecules. Free energy of bind-
ing calculations indicate significant affinity for all crystallographic binding
sites in open and locally closed conformations, in some cases modulated by pH.
[1] Sauguet et al. 2013, Nature communications. 4:1697.
[2] Nury et al. 2011, Nature. 469:428-31.
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Molecular Insights into the Gating Mechanism of GLIC, a Prokaryotic
Ligand-Gated Ion Channel
Mehrnoosh Arrar1, Iman Pouya2, James Andrew McCammon1,
Erik Lindahl2.
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Ligand-gated ion channels (LGICs) mediate intercellular signaling by allow-
ing the selective passage of ions upon neurotransmitter binding. The passage
of ions depends on a delicate conformational equilibrium between open
(active) and closed (resting) states of these proteins. Here we study the clos-
ing mechanism of a prokaryotic homologue of the nicotinic acetylcholine re-
ceptor, called GLIC, which is activated at low pH. Because the only available
structures of GLIC to date are in an open conformation, we simulated a pH
jump to 7, in order to induce channel closure. By starting from different
conformational sub-states, which differed in channel hydration levels and
local conformations of pore-lining residues, we found that multiple confor-
mations, both open and closed, were stable on the microsecond timescale,
even at pH 7, suggesting channel closure may be a slower process than
expected.
